Introduction of a National HPV vaccination program into Bhutan

Vaccine

Volumn 33, Issue 31, 2015, Pages 3726-3730

  Dorji, Tandin ^a   Tshomo, Ugyen ^b   Phuntsho, Sangay ^a   Tamang, Tshewang Dorji ^a   Tshokey, Tshokey ^b   Baussano, Iacopo ^c   Franceschi, Silvia ^c   Clifford, Gary ^c  

^a Ministry of Health   (Bhutan)

^b Royal Government of Bhutan   (Bhutan)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Bhutan; Cervical cancer; Human papillomavirus; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BHUTAN; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER PREVENTION; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CENTER; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); MULTICENTER STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SCHOOL; SCHOOL CHILD; SCREENING TEST; SINGLE DRUG DOSE; UTERINE CERVIX CANCER; VIRUS STRAIN; WART VIRUS; COMPLICATION; HEALTH CARE POLICY; IMMUNOLOGY; PAPILLOMAVIRUS INFECTIONS; PREVENTIVE HEALTH SERVICE; PROCEDURES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

ADOLESCENT; BHUTAN; CHILD; FEMALE; HEALTH POLICY; HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE QUADRIVALENT, TYPES 6, 11, 16, 18; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84937632076     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.05.078     Document Type: Article

References (21)

1. Ferlay J., Soerjomataram I., Ervik M., et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet] 2013, International Agency for Research on Cancer, Lyon, France.
2. Ministry of Health Bhutan health management information system. Annual health bulletin 2012 2012, Ministry of Health, Thimphu, Bhutan.
3. Bhutan Reproductive Health Programme Review Report, 2011.
4. Baussano I., Tshomo U., Clifford G.M., Tenet V., Tshokey T., Franceschi S. Cervical cancer screening program in Thimphu Bhutan: population coverage and characteristics associated with screening attendance. BMC Womens Health 2014, 14:147.
5. Ministry of Health National health survey 2012, Ministry of Health, Thimphu, Bhutan.
6. Tobgay T., Dorji T., Pelzom D., Gibbons R.V. Progress and delivery of health care in Bhutan, the land of the thunder dragon and gross national happiness. Trop Med Int Health 2011, 16(6):731-736.
7. Tobgay T., Dophu U., Torres C.E., Na-Bangchang K. Health and gross national happiness: review of current status in Bhutan. J Multidiscip Healthc 2011, 4:293-298.
8. GAVI honours 15 countries for excelling in immunization and child survival. 19-11-2009. [accessed 05.01.2015]. http://www.gavialliance.org/library/news/press-releases/2009/gavi-honours-15-countries-for-excelling-in-immunisation-and-child-survival/.
9. World Health Organization Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2009, 84(Apr (15)):118-131.
10. National Statistics Bureau Bhutan Multiple Indicator Survey 2011, National Statistics Bureau, Thimphu, Bhutan.
11. Clifford G.M., Smith J.S., Aguado T., Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003, 89(Jul (1)):101-105.
12. Tshomo U., Franceschi S., Dorji D., Baussano I., Tenet V., Snijders P.J., et al. Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis 2014, 14:408.
13. GAVI Alliance Country Eligibility Policy. [last accessed 18 February 2015]. http://www.gavi.org/about/governance/programme-policies/country-eligibility/.
14. Ladner J., Besson M.H., Hampshire R., Tapert L., Chirenje M., Saba J. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health 2012, 12:370.
15. Baussano I., Lazzarato F., Ronco G., Dillner J., Franceschi S. Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries. Int J Cancer 2013, 133(Oct (8)):1876-1881.
16. Dhendup T., Tshering P. Cervical cancer knowledge and screening behaviors among female university graduates of year 2012 attending national graduate orientation program, Bhutan. BMC Womens Health 2014, 14(1):44.
17. Levin A., Wang S.A., Levin C., Tsu V., Hutubessy R. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries. PLOS ONE 2014, 9(6):e101114.
18. World Health Organization Monitoring the coverage and impact of human papillomavirus vaccine-report of WHO meeting, November 2009. Wkly Epidemiol Rec 2010, 25:237-248.
19. Crosbie E.J., Einstein M.H., Franceschi S., Kitchener H.C. Human papillomavirus and cervical cancer. Lancet 2013, 382(Sep (9895)):889-899.
20. Schmitt S. The Kingdom of Bhutan: a combined V3P and immunization financing sustainability mission. World Health Organization-global immunization news Apr, 2012, 14.
21. World Health Organization Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 2014, 890(Oct (43)):465-491.